Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for XIFAXAN
- Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients
- Efficacy and Safety of Rifaximin With NAC in IBS-D
- Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer
- Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
- Autologous Transplant Targeted Against Crohn's
- Rifaximin in Patients With Monoclonal Gammopathy
- Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
- Rifaximin to Modify the Disease Course in Sickle Cell Disease
- MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
- The Effect of Rifaximin on Portal Vein Thrombosis
- Rifaximin on Visceral Hypersensitivity
- Rifaximin in Patients With Gastroesophageal Variceal Bleeding
- Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
- A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
- Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease
- GutHeart: Targeting Gut Microbiota to Treat Heart Failure
- Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection
- Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
- Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
- The Rifaximin Study in CVID
- Rifaximin for Chronic Immune Activation in People With HIV
- The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy
- Quality of Life and Nutritional Improvements in Cirrhotic Patients
- Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
- A Pilot Study of Xifaxan to Treat Patients With PSC
- Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth
- Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
- A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
- Rifaximin Treatment of Papulopustular Rosacea
- Rifaximin in Fatty Liver Disease
- Study of Rifaximin in Minimal Hepatic Encephalopathy
- Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
- Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia
- Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
- Gulf War Digestive Health Study
- Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?
- Induction of Clinical Response Using Rifaximin in Crohn's Disease
- Transit Time and Bacterial Overgrowth Using SmartPill Capsule
- A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Clinical trials list
click for details